A Public Health Imperative: The Need for Meaningful Change in the Trans-Pacific Partnership’s Intellectual Property Chapter
2015
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
A Public Health Imperative: The Need for Meaningful Change in the Trans-Pacific Partnership’s Intellectual Property Chapter
Authors
Published Date
2015
Publisher
Minnesota Journal of Law, Science & Technology
Type
Article
Abstract
In order to address the immense public health inequity in trade and patent law practices, the World Trade Organization (WTO) administered the Agreement on Trade-Related Aspects of Intellectual Property Rights (widely known as TRIPS). The TRIPS Agreement employs various provisions to ensure public health needs are addressed through international trade; these provisions are referred to as “flexibilities.” The past two decades have seen an increasing number of developing nations successfully utilize the flexibilities provided by TRIPS, which aim to lower costs and increase access to medicine by facilitating the importation of generic formulas. While TRIPS has made progress by bringing public health needs on par with global patent rights, many countries have not yet amended their laws to incorporate full TRIPS flexibilities. An increasing number of bilateral and multilateral free trade agreements include intellectual property protections that greatly exceed the minimum intellectual property standards of TRIPS, thus hindering the use of such flexibilities. The advent of the TPP, a proposed trade agreement between twelve countries including the United States,
potentially poses the most aggressive pharmaceutical intellectual property provisions to date. Part I of this Note will review the development of the TPP and its intellectual property provisions as well as the history of trade and medicine, particularly focusing on the restrictions of the TRIPS flexibilities. Part II will specifically discuss how the TPP’s intellectual property provisions will adversely impact global access to affordable medicines and a partner nation’s ability to utilize existing TRIPS flexibilities. Part II will also include recommendations to keep the TPP consistent with TRIPS in
order to balance patent rights for the pharmaceutical industry with broader public health and bioethical goals.
Keywords
Description
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Patel, Roma. (2015). A Public Health Imperative: The Need for Meaningful Change in the Trans-Pacific Partnership’s Intellectual Property Chapter. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/172106.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.